Highlights: Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, providing exclusive access to an extensive package of non-clinical studies and manufacturing...
Read More Details
Finally We wish PressBee provided you with enough information of ( Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 )
Also on site :
- Rough start dooms SB Foresters
- Top Western firms switching to Chinese AI – WSJ
- Palestine Action activists charged over UK base break-in